Tumor necrosis factor α-induced protein 8-like-2 controls microglia phenotype via metabolic reprogramming in BV2 microglial cells and responses to neuropathic pain
Related Experiment Video
Updated: Jul 11, 2026

Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates
Published on: January 30, 2014
Yeqi Li1, Cui Yin2, Jinhong Jiang2
1School of Anesthesiology, Xuzhou Medical University, Xuzhou, Jiangsu, China.
Abstract:
Microglial are major players in neuroinflammation that have recently emerged as potential therapeutic targets for neuropathic pain. Glucose metabolic programming has been linked to differential activation state and function in microglia. Tumor necrosis factor α-induced protein 8-like-2 (TNFAIP8L2) is an important component in regulating the anti-inflammatory response. However, the role of TNFAIP8L2 in microglia differential state during neuropathic pain and its interplay with glucose metabolic reprogramming in microglia has not yet been determined. Thus, we aimed to investigate the role of TNFAIP8L2 in the status of microglia in vitro and in vivo. BV2 microglial cells were treated with lipopolysaccharides plus interferon-gamma (LPS/IFNγ) or interleukin-4 (IL-4) to induce the two different phenotypes of microglia in vitro. In vivo experiments were conducted by chronic constriction injury of the sciatic nerve (CCI). We investigated whether TNFAIP8L2 regulates glucose metabolic programming in BV2 microglial cells. The data in vitro showed that TNFAIP8L2 lowers glycolysis and increases mitochondrial oxidative phosphorylation (OXPHOS) in inflammatory microglia. Blockade of glycolytic pathway abolished TNFAIP8L2-mediated differential activation of microglia. TNFAIP8L2 suppresses inflammatory microglial activation and promotes restorative microglial activation in BV2 microglial cells and in spinal cord microglia after neuropathic pain. Furthermore, TNFAIP8L2 controls differential activation of microglia and glucose metabolic reprogramming through the MAPK/mTOR/HIF-1α signaling axis. This study reveals that TNFAIP8L2 plays a critical role in neuropathic pain, providing important insights into glucose metabolic reprogramming and microglial phenotypic transition, which indicates that TNFAIP8L2 may be used as a potential drug target for the prevention of neuropathic pain.
Insights
Tumor necrosis factor α-induced protein 8-like-2 (TNFAIP8L2) regulates microglial activation and glucose metabolism in neuropathic pain. This protein suppresses inflammation and promotes healing, offering a potential therapeutic target for pain relief.
Area of Science:
- Neuroscience
- Immunology
- Metabolic Research
Background:
- Microglia are key players in neuroinflammation and are implicated in neuropathic pain.
- Glucose metabolic programming influences microglial activation states and functions.
- Tumor necrosis factor α-induced protein 8-like-2 (TNFAIP8L2) is involved in anti-inflammatory responses.
Purpose of the Study:
- To investigate the role of TNFAIP8L2 in microglial activation and its relationship with glucose metabolic reprogramming in neuropathic pain.
- To elucidate the mechanism by which TNFAIP8L2 influences microglial phenotypes.
Main Methods:
- In vitro studies using BV2 microglial cells stimulated with LPS/IFNγ or IL-4 to induce distinct microglial phenotypes.
- In vivo experiments involving chronic constriction injury (CCI) of the sciatic nerve in a neuropathic pain model.
- Analysis of glucose metabolism, including glycolysis and mitochondrial oxidative phosphorylation (OXPHOS), and signaling pathways (MAPK/mTOR/HIF-1α).
Main Results:
- TNFAIP8L2 was found to decrease glycolysis and enhance mitochondrial OXPHOS in inflammatory microglia in vitro.
- Blocking the glycolytic pathway abrogated TNFAIP8L2-mediated microglial activation.
- TNFAIP8L2 suppressed inflammatory microglial activation and promoted restorative activation in both cell cultures and in vivo models of neuropathic pain.
- TNFAIP8L2 regulates microglial activation and glucose metabolism via the MAPK/mTOR/HIF-1α signaling axis.
Conclusions:
- TNFAIP8L2 plays a critical role in modulating microglial phenotypes and glucose metabolism during neuropathic pain.
- The findings provide insights into the interplay between metabolic reprogramming and microglial phenotypic transition.
- TNFAIP8L2 represents a potential therapeutic target for the prevention and treatment of neuropathic pain.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

